Related Experiment Video
Updated: Jul 11, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
Genetically delivered antibody protects against West Nile virus
Alexander Pereboev1, Viktoriya Borisevich, George Tsuladze
1Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham 35294-2172, USA. pereboev@uab.edu
Abstract:
Gene-based delivery of recombinant antibody genes is a promising therapeutic strategy offering numerous advantages including sustained antibody levels, better safety profile and lower production cost. Here we describe generation of a recombinant antibody Fc-9E2 comprising a fusion protein between human Fc of IgG1 and a single-chain Fv derived from a hybridoma 9E2 secreting a mAb neutralizing West Nile virus (WNV). Fc-9E2 was shown to retain parental mAb's specificity and WNV-neutralizing capacity. Adenovirus-mediated in vivo delivery of the antibody gene resulted in sustained Fc-9E2 serum levels leading to abrogation of lethal WNV infection in an animal model.
Related Concept Videos
Arboviral Encephalitis
Cross-reactivity
Yellow Fever
Respiratory Syncytial Virus Disease

